Erratum to "Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)" [Eur Urol Oncol 2021;4:543-52].

ABSTRACT:

SUBMITTER: Morris MJ 

PROVIDER: S-EPMC10545163 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature